Company Analysis

GeoVax Labs, Inc. (GOVX)

Nasdaq: GOVX · Pharmaceutical Preparations · Smyrna, GA · filing with the SEC since 1996
Grade4.4
◀ Past 2.1● Present 4.8▶ Future 5.5
1 est.

Filings

479 filings since 2017 beside 109 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Sep 10, 2026.

Filings a yearinsider forms included
3655475548989387
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Nov 9, 2026.Listing warning from its exchange (8-K item 3.01): 8 times in the last 36 months, the newest Aug 28, 2026.SEC letters: 26 in the last 36 months, the newest Jun 1, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.
Insider forms 109

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 3.03, 5.03, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report Nov 10, 2026
Nov 9, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Nov 5, 2026
Nov 6, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Nov 5, 2026
Nov 4, 2026 S-1 Listing registration
Oct 27, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report
Oct 27, 2026 8-K items 1.01, 2.03, 3.03, 5.02, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Change to shareholders' rights; Officer or director change; Investor disclosure (Regulation FD) · Current report Oct 23, 2026
Oct 27, 2026 DRS/A Draft registration, confidential, amended
Sep 23, 2026 EFFECT Registration effective
Sep 17, 2026 S-1 Listing registration
Sep 10, 2026 DEF 14A Proxy statement Oct 27, 2026
Sep 10, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 31, 2026 PRE 14A Preliminary proxy statement Oct 27, 2026
Aug 28, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Aug 27, 2026
Aug 28, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report Aug 25, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 10, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 30, 2026 DRS Draft registration, confidential
Jul 27, 2026 10-Q Quarterly report Jun 30, 2026
Jul 27, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 10, 2026 8-K item 3.01 Listing warning from its exchange · Current report Jul 7, 2026
Jun 17, 2026 8-K item 5.07 Shareholder vote · Current report
Jun 9, 2026 SCHEDULE 13G Large holder notice
Jun 3, 2026 EFFECT Registration effective
Jun 1, 2026 CORRESP Reply to the SEC
Jun 1, 2026 UPLOAD SEC comment letter
May 26, 2026 S-1 Listing registration
May 19, 2026 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report May 18, 2026
May 18, 2026 DEFR14A Revised proxy statement
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 13, 2026 SCHEDULE 13G/A Large holder update, amended
May 8, 2026 PRER14A Form PRER14A
May 7, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report
Apr 27, 2026 DEF 14A Proxy statement Jun 17, 2026
Apr 21, 2026 EFFECT Registration effective
Apr 21, 2026 EFFECT Registration effective
40 of 479 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton GOVX · research, not advice